 |
answer text |
<p>NHS England, in collaboration with the Medicines and Healthcare products Regulatory
Agency (MHRA), has carried out the following activities in relation to developing
the National Medication Safety Network:</p><p> </p><p> </p><p> </p><p>- Undertaken
nine web events with presentations and recordings posted to the <a href="http://www.patientsafetyfirst.nhs.uk/"
target="_blank">www.patientsafetyfirst.nhs.uk</a> web forum accessed by Medication
Safety Officers (MSOs). A total of 699 MSOs have participated in these formal web
meetings.</p><p> </p><p>- Run a conference for MSOs on 19 January 2015 with keynote
speakers from NHS England, MHRA and the National Reporting and Learning System with
150 MSOs in attendance.</p><p> </p><p>- Run dedicated web events for the 18 Community
Pharmacy MSOs.</p><p> </p><p>- Are arranging one-day regional meetings on 10 March
2015 (London), 15 July 2015 (Midlands) 12 May (South), 14 October (North) inviting
70-100 MSOs. A key aim of these events is to provide the opportunity for MSOs to feedback
in person to NHS England and the MHRA on development of the MSO role.</p><p> </p><p>-
We have dedicated (0.4 full-time equivalent) support for development of the MSO role
from the Specialist Pharmacy Service. The remit includes monitoring of engagement
by MSOs in the network.</p><p> </p><p> </p><p> </p><p>Although the NHS England Medication
Safety team have not yet received any formal representations from national patient
groups, MSOs have been encouraged to liaise with their local organisation ‘patient
and public voice’ leads to help recruit patients onto their medication safety committees.</p><p>
</p><p> </p><p> </p><p>Members of the public and patient groups can also make enquiries
directly to NHS England.</p><p> </p>
|
|
